Showing results (321-330 of 352) with videos related to
Sort By:
Pageof 36
The New England Journal of Medicine|January 30, 2020
Soluble Urokinase Receptor and Acute Kidney InjurySalim S Hayek, David E Leaf, Ayman Samman Tahhan, et al.Journal of the American Heart Association|December 10, 2021
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19Michael Pan, Alexi Vasbinder, Elizabeth Anderson, et al.Journal for Immunotherapy of Cancer|July 11, 2023
Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancerSachin R Jhawar, Shang-Jui Wang, Aditya Thandoni, et al.Cell Metabolism|October 7, 2015
Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular HypertrophyAlexander Grabner, Ansel P Amaral, Karla Schramm, et al.The Journal of Clinical Investigation|September 14, 2011
CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survivalSuma Yaddanapudi, Mehmet M Altintas, Andreas D Kistler, et al.Journal of the American Society of Nephrology : JASN|March 29, 2014
Role of podocyte B7-1 in diabetic nephropathyPaolo Fiorina, Andrea Vergani, Roberto Bassi, et al.Journal of the American Society of Nephrology : JASN|September 23, 2020
Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKITariq U Azam, Husam R Shadid, Pennelope Blakely, et al.Kidney International|March 23, 2019
Health-related quality of life in glomerular diseasePietro A Canetta, Jonathan P Troost, Shannon Mahoney, et al.Diabetes Care|January 19, 2022
Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19Alexi Vasbinder, Elizabeth Anderson, Husam Shadid, et al.Critical Care Medicine|February 23, 2024
Intubation Decision Based on Illness Severity and Mortality in COVID-19: An International StudyAthanasios Chalkias, Yiyuan Huang, Anis Ismail, et al.Pageof 36